Tag Archives: CLSD

Top 10 Value Stocks To Buy For 2019

The big day is rapidly approaching. In just over a month, on Oct. 17, recreational marijuana will go on sale in licensed dispensaries throughout Canada. When fully legal, the sale of adult-use weed is expected to usher in high demand and big dollar figures for the industry.

In anticipation of this legalization — and the big profits that are projected to follow — marijuana stock investors and Wall Street have pushed the valuations of many pot stocks into nosebleed territory. Some of these marijuana stocks are still valued modestly below Wall Street’s consensus price target per share. Conversely, there are a handful of top marijuana stocks whose price targets are well below their current share price. Keeping in mind that Wall Street price targets are nothing more than dart throws by analysts, here are three top marijuana stocks that are expected to lose at least a quarter of their value.

Image source: Getty Images.

Top 10 Value Stocks To Buy For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Sean Williams]

    Meanwhile, Medifast’s (NYSE:MED) share price has tripled since the beginning of March. Medifast’s second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

Top 10 Value Stocks To Buy For 2019: Hingham Institution for Savings(HIFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Port Capital LLC lifted its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 14.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,159 shares of the savings and loans company’s stock after purchasing an additional 5,943 shares during the quarter. Hingham Institution for Savings accounts for approximately 1.4% of Port Capital LLC’s holdings, making the stock its 25th biggest position. Port Capital LLC owned approximately 2.28% of Hingham Institution for Savings worth $9,921,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Hingham Institution for Savings (NASDAQ:HIFS) and SVB Financial Group (NASDAQ:SIVB) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. grew its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 71.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 92,261 shares of the savings and loans company’s stock after purchasing an additional 38,440 shares during the quarter. Epoch Investment Partners Inc. owned approximately 4.37% of Hingham Institution for Savings worth $19,006,000 as of its most recent SEC filing.

Top 10 Value Stocks To Buy For 2019: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos, Jeremy Bowman, and Steve Symington]

    With that in mind, Motley Fool investors scoured the industry for examples of retailers that boast attractive long-run growth opportunities. Read on to find out why Five Below (NASDAQ:FIVE), lululemon (NASDAQ:LULU), and Boot Barn (NYSE:BOOT) topped that list. 

  • [By Jeremy Bowman]

    Meanwhile, Under Armour’s rivals like Nike (NYSE:NKE), Adidas (NasdaqOTC: ADDYY), and lululemon athletica (NASDAQ:LULU) all performed well in the survey. Piper Jaffray found that Adidas was the fastest-growing brand in the survey, which follows Adidas’s recent stock surge and sales and profit growth. Its Originals, or classic sneakers, like the Stan Smith and the Superstar were especially popular last year. The Superstar, in fact, was the No. 1-selling sneaker last year, according to NPD Group, dethroning Nike for the first time in more than a decade.  

  • [By John Ballard]

    However, Nike’s core business is still selling sneakers. That’s not going to change, and that’s also why lululemon athletica (NASDAQ:LULU) should continue to do fine. Just as Nike has been successful turning a basketball shoe into a fashion statement, Lululemon has accomplished the same in athletic apparel. Both companies are really good at what they do best, and that will protect Lululemon’s competitive position from larger rivals.

Top 10 Value Stocks To Buy For 2019: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 10 Value Stocks To Buy For 2019: Amtech Systems Inc.(ASYS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine cut shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell rating in a research note published on Wednesday morning.

    Separately, Zacks Investment Research raised Amtech Systems from a sell rating to a hold rating in a research report on Monday, April 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $14.88.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    SUMITOMO HEAVY/ADR (NASDAQ: ASYS) and Amtech Systems (NASDAQ:ASYS) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Top 10 Value Stocks To Buy For 2019: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Top 10 Value Stocks To Buy For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Scott Levine]

    In one of the gold industry’s most notable news stories last month, Goldcorp announced that it had entered into a definitive agreement with Newmont Mining (NYSE:NEM) in which Newmont will acquire all outstanding shares of Goldcorp’s common stock in a deal valued at $10 billion. Newmont will acquire each Goldcorp share for 0.3280 of a Newmont share, representing a 17% premium based on the companies’ 20-day volume weighted average share prices. The transaction is expected to close in the second quarter of 2019 and has already been approved by both companies’ boards of directors.

  • [By Trey Thoelcke]

    Newmont Mining Corp. (NYSE: NEM) is scheduled to report its fourth-quarter results before Thursday’s open. The consensus estimates call for EPS of $0.25 and $1.88 billion in revenue. Shares closed at $33.24 on Friday. The consensus price target is $40.00, and the 52-week trading range is $29.06 to $41.98.

  • [By Paul Ausick]

    Just a week ago today, Barrick Gold Corp. (NYSE: GOLD) announced an unsolicited offer to acquire rival miner Newmont Mining Corp. (NYSE: NEM) for $18 billion. The all-stock offer was rejected Monday morning by Newmont’s board of directors in a decision that was entirely predictable. Less predictable, perhaps, was Newmont’s counteroffer of a joint venture between the two firms’ Nevada operations.

  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

Top 10 Value Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

  • [By Chris Lange]

    Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Ethan Ryder]

    Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

Top 10 Value Stocks To Buy For 2019: Bassett Furniture Industries Incorporated(BSET)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Bassett Furniture Industries (NASDAQ:BSET) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bassett Furniture Industries earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.0883846805754 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Value Stocks To Buy For 2019: Eaton Vance Short Diversified Income Fund(EVG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EATON VANCE SHO/COM (NYSE:EVG) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Investors of record on Friday, September 21st will be paid a dividend of 0.065 per share on Friday, September 28th. This represents a $0.78 dividend on an annualized basis and a yield of 6.06%. The ex-dividend date is Thursday, September 20th.

Top Growth Stocks To Buy For 2019

The stock market mostly bounced higher on Wednesday following losses earlier in the week, with the Nasdaq Composite vaulting to new highs on strength in technology stocks. investors have gravitated toward the highest-growth areas of the market, leaving slower-growing value stocks behind in many cases. Good news from several individual companies also helped lift their share prices. Winnebago Industries (NYSE:WGO), Synaptics (NASDAQ:SYNA), and Tesaro (NASDAQ:TSRO) were among the best performers on the day. Here’s why they did so well.

Winnebago hits the gas

Shares of Winnebago Industries jumped 15% after the recreational vehicle specialist announced its fiscal third-quarter financial results. Winnebago said that sales climbed to record levels during the quarter, helping earnings jump by two-thirds from the year-ago period. As CEO Michael Happe noted, “New product performance, our evolving portfolio mix, and agility in managing cost pressures all contributed nicely to our third quarter results.” The only potential headwind down the road could come from inflationary pressure in obtaining the raw materials necessary to manufacture its RVs, but for the most part, Winnebago is confident that it can use cost-cutting measures elsewhere to insulate its bottom line from any potential negative impact.

Top Growth Stocks To Buy For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

  • [By Sean Williams]

    With this in mind, here are the pot stocks offering the highest revenue potential in fiscal 2019, listed in descending order:

    Aurora Cannabis (NYSE:ACB): $244.5 million The Green Organic Dutchman: $227.1 million Canopy Growth (NYSE:CGC): $190.4 million MedMen Enterprises: $188.9 million iAnthus Capital Holdings (NASDAQOTH:ITHUF): $181.4 million Village Farms International: $147.6 million GW Pharmaceuticals: $123 million KushCo Holdings (NASDAQOTH:KSHB): $117.9 million Aphria (NYSE:APHA): $107.4 million CannTrust Holdings: $105.5 million

    Image source: Getty Images.

  • [By Javier Hasse]

    Licensed cannabis production facilities owner and operator iAnthus Capital Holdings Inc (OTC: ITHUF) announced a $50 million investment from Gotham Green Partners. Management believes this is the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company. iAnthus plans to allocate the proceeds of this financing to repay a $20 million one-year note and accrued interest to VCP Bridge LLC; continue to build out cultivation facilities and dispensaries in the New York and Florida markets; and, potentially, to expand activities. The remaining expenditures for completing iAnthus’ Massachusetts and Vermont operations will be funded with current cash on hand, management assured.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days (percentages reflect approximate equity moves as of the time of the writing of this article.

    22nd Century Group Inc (NYSE: XXII): up 4.5 percent
    Aphria Inc (OTC: APHQF): down 1.4 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.6 percent
    Cannabis Sativa Inc (OTC: CBDS): down 6.3 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.3 percent
    Canopy Growth Corp (NYSE: CGC): up 1.8 percent
    Cronos Group Inc. (NASDAQ: CRON): up 9.3 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.2 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 15.5 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 1.9 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.6 percent
    MassRoots Inc (OTC: MSRT): down 0.2 percent
    MedReleaf Corp(OTC: MEDFF): up 1.1 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.6 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 5.5 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): up 7.3 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Sean Williams]

    For instance, iAnthus Capital Holding (NASDAQOTH:ITHUF) recently completed the largest U.S. deal to date by purchasing MPX Bioceutical for around $600 million. (This deal will be eclipsed by MedMen’s purchase of PharmaCann, once that deal closes.) Though it’s unclear what sort of premium iAnthus paid for MPX Bioceutical as of yet, a quick glance at iAnthus Capital’s balance sheet shows that 55% of its total assets are currently tied up in goodwill. Since the dispensary space will presumably have plenty of competition, it’s unclear if iAnthus (or other acquisition-hungry dispensaries) will be able to recoup the premium it’s paid to buy other businesses. This leaves the door open for hefty future writedowns.

Top Growth Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Clearside Biomedical (NASDAQ:CLSD) are down 26% at 12:47 p.m. EDT after the company announced what it called “positive topline results” from the phase 2 Tybee trial testing its steroid treatment, CLS-TA, in patients with an eye disease called diabetic macular edema.

  • [By Shane Hupp]

    MetLife Investment Advisors LLC purchased a new position in shares of Clearside Biomedical Inc (NASDAQ:CLSD) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,859 shares of the company’s stock, valued at approximately $117,000.

  • [By Chris Lange]

    Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Ethan Ryder]

    Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

Top Growth Stocks To Buy For 2019: E-House(China)

Advisors’ Opinion:

  • [By ]

    The world’s largest operating utility-scale solar projects are concentrated in China and India, according to IEEFA. Based on company and press reports, as well as its own estimates, those include:

    RankingProject NameSize MWCountryProponent 1Tengger Desert Solar Park1,547ChinaChina National Grid Zhongwei Power Supply Co2Kurnool Ultra Mega Solar Park1,000IndiaAndhra Pradesh Solar Power Corporation Pvt Ltd3Datong Solar Power Top Runner Base1,000ChinaMultiple4Yanchi Ningxia Solar Park1,000ChinaHuawei Technologies Co5Longyangxia Dam Solar Park850ChinaState Power Investment Corporation (China)6Adani Kamuthi Solar Plant648IndiaAdani Green7Solar Star579U.S.BHE Renewables8Topaz Solar Farm550U.S.First Solar9Desert Sunlight Solar Farm550U.S.NextEra Energy, GE Energy Financial & Sumitomo10Nova Olinda Solar Farm292BrazilEnel Green Power

    China added 53 gigawatts of the 98 gigawatts of new solar capacity built last year, a 31 percent increase from the total 2017, IEEFA said, citing Bloomberg New Energy Finance data. Meanwhile, the per unit cost of electricity over the life of a generating asset fell 15 percent year-on-year to $86 a megawatt hour.

Top 5 Safest Stocks To Own For 2019

The anxiety, frustration and second-guessing builds during times like these, but you must remain vigilant and, more important, patient.

Since the market peaked at the end of January and subsequently slid into its first correction in two years, we’ve been patiently waiting to see whether this is “just” a correction or if it’s the start of the next bear market.

—Recommended Link— The Most Generous Income Producers You Can Get
We’re sitting on a collection of the safest, most generous monthly payers available. And while $11,200 in dividend checks is a welcome addition to anyone’s income, investors also love racking up capital gains as high as 446%.Start generating a 10%+ income stream for life today from these consistent companies.

But as the market consolidates before its next move, the anticipation can be almost too much for many investors. In times like these, mistakes are made and money is lost. Investing strategies and discipline get tossed out the window as traders base their next move on the daily swings of the market. Euphoria climbs when the S&P 500 ends the day in green, but it quickly fades the next day when the market opens lower.

Top 5 Safest Stocks To Own For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Clearside Biomedical (NASDAQ:CLSD)are down 26% at 12:47 p.m. EDT after the company announcedwhat it called “positive topline results” from the phase 2 Tybee trial testing its steroid treatment, CLS-TA, in patients with an eye disease called diabetic macular edema.

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Lisa Levin]

    Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

  • [By Max Byerly]

    Clearside Biomedical (NASDAQ:CLSD) is scheduled to release its earnings data before the market opens on Wednesday, August 8th. Analysts expect Clearside Biomedical to post earnings of ($0.57) per share for the quarter.

  • [By Shane Hupp]

    MetLife Investment Advisors LLC purchased a new position in shares of Clearside Biomedical Inc (NASDAQ:CLSD) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,859 shares of the company’s stock, valued at approximately $117,000.

Top 5 Safest Stocks To Own For 2019: New Oriental Education & Technology Group, Inc.(EDU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    New Oriental (NYSE: EDU) and The Graham (NYSE:GHC) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Strayer Education (NASDAQ: STRA) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

  • [By Ethan Ryder]

    EduCoin (EDU) is a PoW/PoS token that uses the Keccak hashing algorithm. It launched on September 9th, 2017. EduCoin’s total supply is 15,000,000,000 tokens. EduCoin’s official website is www.edu.one. EduCoin’s official Twitter account is @PReducoin.

  • [By Ethan Ryder]

    Russell Investments Group Ltd. lessened its holdings in New Oriental (NYSE:EDU) by 6.2% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 550,160 shares of the company’s stock after selling 36,191 shares during the period. Russell Investments Group Ltd. owned 0.35% of New Oriental worth $48,090,000 as of its most recent SEC filing.

Top 5 Safest Stocks To Own For 2019: Xerox Corporation(XRX)

Advisors’ Opinion:

  • [By ]

    Here’s everything you must know before Friday’s opening bell: 

    Warren Buffett has reportedly purchased 75 million more shares of Apple (AAPL) .  Xerox (XRX) said its board & management team will remain in place after a settlement with Carl Icahn & Darwin Deason expired. Twitter (TWTR) has told all users they should change their passwords. U.S. stock futures pointed lower ahead of the U.S. jobs report. Join Jim Cramer on May 5 in New York City for an exclusive investing boot camp. Secure your spot here.

    Subscribe to our Youtube Channel for extended interviews, Cramer Replays, feature content, and more!

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Xerox (XRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    1. Xerox (NYSE: XRX)
    Falling off its highs to below support at the 50- and 200-day simple moving averages (SMAs), the original digital print company is higher by under 3% in 2018. However, due to the way the company’s pension plan is structured, it stands to benefit significantly from climbing rates. Let me explain.

Top 5 Safest Stocks To Own For 2019: Nuveen North Carolina Premium Income Municipal Fund(NNC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Wells Fargo & Company MN increased its holdings in Nuveen North Carol Premium Incom Mun Fd (NYSE:NNC) by 29.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 289,655 shares of the financial services provider’s stock after purchasing an additional 66,507 shares during the quarter. Wells Fargo & Company MN’s holdings in Nuveen North Carol Premium Incom Mun Fd were worth $3,554,000 at the end of the most recent reporting period.

Top 5 Safest Stocks To Own For 2019: Aimia Inc. (GAPFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada’s decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

Top 10 Heal Care Stocks To Buy For 2019

Brokerages predict that Plexus Corp. (NASDAQ:PLXS) will report sales of $720.44 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Plexus’ earnings. The lowest sales estimate is $720.00 million and the highest is $720.91 million. Plexus reported sales of $618.83 million in the same quarter last year, which indicates a positive year-over-year growth rate of 16.4%. The business is scheduled to announce its next earnings report on Wednesday, July 18th.

According to Zacks, analysts expect that Plexus will report full-year sales of $2.83 billion for the current financial year. For the next fiscal year, analysts forecast that the firm will report sales of $3.05 billion per share, with estimates ranging from $3.03 billion to $3.09 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Plexus.

Top 10 Heal Care Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

  • [By Shane Hupp]

    MetLife Investment Advisors LLC purchased a new position in shares of Clearside Biomedical Inc (NASDAQ:CLSD) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,859 shares of the company’s stock, valued at approximately $117,000.

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

  • [By Keith Noonan]

    Clearside Biomedical, Inc. Stock (NASDAQ:CLSD)stock rose 66.1% in March, according to data provided byS&P Global Market Intelligence.

Top 10 Heal Care Stocks To Buy For 2019: CIRCOR International, Inc.(CIR)

Advisors’ Opinion:

  • [By Max Byerly]

    CIRCOR International (NYSE: CIR) and ARC Group WorldWide (NASDAQ:ARCW) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CIRCOR International (CIR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CIRCOR International (CIR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CIRCOR International (CIR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Peel Hunt reaffirmed their hold rating on shares of Circassia Pharmaceuticals (LON:CIR) in a report published on Thursday.

    A number of other research analysts have also recently commented on the company. Numis Securities decreased their price target on Circassia Pharmaceuticals from GBX 180 ($2.42) to GBX 140 ($1.88) and set a buy rating on the stock in a research report on Tuesday, April 24th. JPMorgan Chase & Co. restated a neutral rating on shares of Circassia Pharmaceuticals in a research report on Tuesday, April 24th.

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get CIRCOR International alerts:

    CIRCOR International, Inc. Forecasted to Earn Q2 2018 Earnings of $0.50 Per Share (CIR) (americanbankingnews.com) CIRCOR Mexico Earns API Certifications for Quality Management (finance.yahoo.com) SunTrust Banks Research Analysts Boost Earnings Estimates for CIRCOR International, Inc. (CIR) (americanbankingnews.com) CIRCOR International (CIR) Lowered to Strong Sell at ValuEngine (americanbankingnews.com) CIRCOR International (CIR) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com)

    A number of research firms have issued reports on CIR. ValuEngine downgraded CIRCOR International from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd. Zacks Investment Research upgraded CIRCOR International from a “sell” rating to a “buy” rating and set a $47.00 price target for the company in a report on Tuesday, May 1st. SunTrust Banks restated a “buy” rating and set a $56.00 price target on shares of CIRCOR International in a report on Friday, March 2nd. Finally, Stifel Nicolaus restated a “buy” rating and set a $54.00 price target (down from $61.00) on shares of CIRCOR International in a report on Thursday, March 1st. Three analysts have rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $57.50.

Top 10 Heal Care Stocks To Buy For 2019: Smith(ds)

Advisors’ Opinion:

  • [By Logan Wallace]

    Redwood Trust (NYSE: RWT) and Drive Shack (NYSE:DS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk.

  • [By Ethan Ryder]

    Drive Shack Inc (NYSE:DS)’s share price hit a new 52-week high and low during trading on Thursday . The company traded as low as $7.18 and last traded at $6.91, with a volume of 21368 shares trading hands. The stock had previously closed at $7.04.

Top 10 Heal Care Stocks To Buy For 2019: ClearBridge American Energy MLP Fund Inc.(CBA )

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about ClearBridge American Energy MLP Fund (NYSE:CBA) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ClearBridge American Energy MLP Fund earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the investment management company an impact score of 47.3026009142931 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Heal Care Stocks To Buy For 2019: Trinity Industries Inc.(TRN)

Advisors’ Opinion:

  • [By ]

    5. Trinity Industries (NYSE: TRN)
    This industrial company is trading lower by over 15% in 2018. A substantial shareholder named Valueact Holdings has purchased over one million shares in the $32.00 range.

  • [By Stephan Byrd]

    Clearline Capital LP boosted its position in shares of Trinity Industries Inc (NYSE:TRN) by 306.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 241,769 shares of the transportation company’s stock after acquiring an additional 182,296 shares during the quarter. Trinity Industries accounts for 7.3% of Clearline Capital LP’s portfolio, making the stock its 4th biggest holding. Clearline Capital LP’s holdings in Trinity Industries were worth $7,889,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Trinity Industries Inc (NYSE:TRN) was up 1.1% during trading on Monday . The company traded as high as $34.53 and last traded at $34.48. Approximately 77,366 shares changed hands during trading, a decline of 96% from the average daily volume of 1,960,164 shares. The stock had previously closed at $34.10.

Top 10 Heal Care Stocks To Buy For 2019: PCM, Inc.(PCMI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on PCM (PCMI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Lisa Levin]

    On Thursday, the information technology shares gained 2.23 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 14 percent.

  • [By Ethan Ryder]

    PCM (NASDAQ: PCMI) and Insight Enterprises (NASDAQ:NSIT) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

  • [By Lisa Levin]

    Thursday afternoon, the information technology shares gained 2.42 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 13 percent.

  • [By Shane Hupp]

    PCM (NASDAQ: PCMI) is one of 20 publicly-traded companies in the “Catalog & mail-order houses” industry, but how does it compare to its competitors? We will compare PCM to similar companies based on the strength of its dividends, institutional ownership, valuation, profitability, risk, analyst recommendations and earnings.

Top 10 Heal Care Stocks To Buy For 2019: Blackbaud, Inc.(BLKB)

Advisors’ Opinion:

  • [By Max Byerly]

    Blackbaud, Inc. (NASDAQ:BLKB) EVP Kevin W. Mooney sold 9,669 shares of the company’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $105.00, for a total value of $1,015,245.00. Following the transaction, the executive vice president now directly owns 99,226 shares of the company’s stock, valued at $10,418,730. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Heal Care Stocks To Buy For 2019: Rowan Companies Inc.(RDC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Max Byerly]

    Shares of Rowan Companies PLC (NYSE:RDC) rose 0.8% during mid-day trading on Thursday . The company traded as high as $16.36 and last traded at $16.09. Approximately 144,835 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 2,492,971 shares. The stock had previously closed at $16.22.

  • [By Shane Hupp]

    California Public Employees Retirement System reduced its position in Rowan Companies PLC (NYSE:RDC) by 5.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 656,438 shares of the oil and gas company’s stock after selling 41,386 shares during the quarter. California Public Employees Retirement System owned 0.52% of Rowan Companies worth $7,575,000 as of its most recent SEC filing.

Top 10 Heal Care Stocks To Buy For 2019: Foot Locker, Inc.(FL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Foot Locker, Inc. (NYSE: FL) reported better-than-expected results for its first quarter.
    Hibbett Sports, Inc. (NASDAQ: HIBB) reported weaker-than-expected results for its first quarter.
    Ross Stores, Inc. (NASDAQ: ROST) reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Gap Inc (NYSE: GPS) posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.

  • [By Steve Symington]

    Shares of Foot Locker Inc. (NYSE:FL) were up 13.5% as of 11:00 a.m. EDT Friday after the footwear retailer announced better-than-expected fiscal first-quarter 2018 results.

  • [By Chris Lange]

    When Foot Locker Inc. (NYSE: FL) released its fiscal first-quarter financial results before the markets opened on Friday, the company said that it had $1.45 in earnings per share (EPS) on $2.03 billion in revenue. That compared with consensus estimates from Thomson Reuters of $1.25 in EPS on revenue of $1.96 billion. The same period of last year reportedly had EPS of $1.36 and $2.0 billion in revenue.

Top 10 Heal Care Stocks To Buy For 2019: Tsakos Energy Navigation Ltd(TNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Stifel Financial Corp lifted its stake in shares of TSAKOS ENERGY N/SH (NYSE:TNP) by 88.5% in the 1st quarter, Holdings Channel reports. The firm owned 392,994 shares of the shipping company’s stock after buying an additional 184,547 shares during the quarter. Stifel Financial Corp’s holdings in TSAKOS ENERGY N/SH were worth $1,301,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Motley Fool Staff]

    Tsakos Energy Navigation (NYSE:TNP) Q1 2018 Earnings Conference CallJun. 15, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Tsakos Energy Navigation (TNP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com